JOSEPH SANDE: Open Payments
NPI 1003367970 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,073 in 33 payments from 9 companies in 2025. Trend: 2023 $325 · 2024 $782 · 2025 $1,073
Food & beverage: $1,073
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 12 | $277 |
| AstraZeneca Pharmaceuticals LP | 3 | $214 |
| Novo Nordisk Inc | 4 | $185 |
| Exact Sciences Corporation | 6 | $157 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $120 |
| ABBVIE INC. | 4 | $71 |
| Phathom Pharmaceuticals, Inc. | 1 | $20 |
| Paratek Pharmaceuticals, Inc. | 1 | $16 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $14 |
Products named: REPATHA, FARXIGA, Ozempic, The Cologuard Plus Collection Kit, Kerendia, OTEZLA, SYNTHROID, BREZTRI.
Industry payments across TX — which companies pay providers there.
